Meta-analysis of survival based on resection margin status following surgery for recurrent rectal cancer

Colorectal Disease

Volumn 14, Issue 12, 2012, Pages 1457-1466

  Bhangu, A ^a,b   Ali, S M ^a,b   Darzi, A ^c   Brown, G ^a   Tekkis, P P ^a,b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Exenteration; Recurrent rectal cancer; Resection margin

Indexed keywords

CANCER SURGERY; CANCER SURVIVAL; EVISCERATION; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM ANTERIOR RESECTION; RECTUM CANCER; RECURRENT CANCER; REVIEW; SYSTEMATIC REVIEW;

CONFIDENCE INTERVALS; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RECTAL NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84866104813     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2012.03005.x     Document Type: Review

References (40)

1. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-60.
2. Nicholls RJ, Tekkis PP. Multidisciplinary treatment of cancer of the rectum: a European approach. Surg Oncol Clin N Am 2008; 17: 533-51, viii.
3. Hansen MH, Balteskard L, Dorum LM, Eriksen MT, Vonen B. Locally recurrent rectal cancer in Norway. Br J Surg 2009; 96: 1176-82.
4. Tepper JE, O'Connell M, Hollis D, Niedzwiecki D, Cooke E, Mayer RJ. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114. J Clin Oncol 2003; 21: 3623-8.
5. Bakx R, van Tinteren H, van Lanschot JJ, Zoetmulder FA. Surgical treatment of locally recurrent rectal cancer. Eur J Surg Oncol 2004; 30: 857-63.
6. Nielsen MB, Laurberg S, Holm T. Current management of locally recurrent rectal cancer. Colorectal Dis 2011; 13: 732-42.
7. Dresen RC, Gosens MJ, Martijn H et al. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 2008; 15: 1937-47.
8. Wiig JN, Larsen SG, Dueland S, Flatmark K, Giercksky KE. Salvage surgery for locally recurrent rectal cancer: total mesorectal excision during the primary operation does not influence the outcome. Colorectal Dis 2011; 13: 506-11.
9. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700.
10. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998; 17: 2815-34.
11. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127: 820-6.
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
13. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 2001; 323: 334-6.
14. Alektiar KM, Zelefsky MJ, Paty PB et al. High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer. Int J Radiat Oncol Biol Phys 2000; 48: 219-26.
15. Heriot AG, Byrne CM, Lee P et al. Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 2008; 51: 284-91.
16. Kakuda JT, Lamont JP, Chu DZ, Paz IB. The role of pelvic exenteration in the management of recurrent rectal cancer. Am J Surg 2003; 186: 660-4.
17. Kanemitsu Y, Hirai T, Komori K, Kato T. Prediction of residual disease or distant metastasis after resection of locally recurrent rectal cancer. Dis Colon Rectum 2010; 53: 779-89.
18. Pacelli F, Tortorelli AP, Rosa F et al. Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy. Ann Surg Oncol 2010; 17: 152-62.
19. Rahbari NN, Ulrich AB, Bruckner T et al. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?Ann Surg 2011; 253: 522-33.
20. Rutten HJ, Mannaerts GH, Martijn H, Wiggers T. Intraoperative radiotherapy for locally recurrent rectal cancer in The Netherlands. Eur J Surg Oncol 2000; 26(Suppl A): S16-20.
21. Asoglu O, Karanlik H, Muslumanoglu M et al. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol 2007; 33: 1199-206.
22. Bohm B, Helfritzsch H, Thiele M, Altendorf-Hofmann A, Scheele J. [Therapy results of locoregional recurrences in rectal cancer]. Zentralbl Chir 2001; 126: 596-601.
23. Palmer G, Martling A, Cedermark B, Holm T. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 2007; 14: 447-54.
24. Park JK, Kim YW, Hur H et al. Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection. Langenbecks Arch Surg 2009; 394: 71-7.
25. Sagar PM, Gonsalves S, Heath RM, Phillips N, Chalmers AG. Composite abdominosacral resection for recurrent rectal cancer. Br J Surg 2009; 96: 191-6.
26. You YN, Habiba H, Chang GJ, Rodriguez-Bigas MA, Skibber JM. Prognostic Value of Quality of Life and Pain in Patients with Locally Recurrent Rectal Cancer. Ann Surg Oncol 2011; 18: 989-96.
27. Wells BJ, Stotland P, Ko MA et al. Results of an aggressive approach to resection of locally recurrent rectal cancer. Ann Surg Oncol 2007; 14: 390-5.
28. Fuzun M. Locoregional recurrence (non hepatic abdominal recurrence) of rectal cancer. Acta Chir Iugosl 2004; 51: 69-71.
29. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006;333:779.
30. Augestad KM, Lindsetmo RO, Stulberg J et al. International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams. World J Surg 2010; 34: 2689-700.
31. Sasapu KK, Sebag-Montefiore D, Chalmers AG, Sagar PM, Burke D, Finan PJ. Evaluation of a protocol-based management of rectal cancer. Dis Colon Rectum 2006; 49: 1703-9.
32. Boyle KM, Sagar PM, Chalmers AG, Sebag-Montefiore D, Cairns A, Eardley I. Surgery for locally recurrent rectal cancer. Dis Colon Rectum 2005; 48: 929-37.
33. Dozois EJ, Privitera A, Holubar SD et al. High sacrectomy for locally recurrent rectal cancer: can long-term survival be achieved?J Surg Oncol 2011; 103: 105-9.
34. Mohiuddin M, Hayne M, Regine WF et al. Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys 2000; 48: 1075-80.
35. Rodel C, Grabenbauer GG, Matzel KE et al. Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum 2000; 43: 312-9.
36. Valentini V, Morganti AG, Gambacorta MA et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase II study. Int J Radiat Oncol Biol Phys 2006; 64: 1129-39.
37. Caravatta L, Picardi V, Tambaro R et al. Neoadjuvant accelerated concomitant boost radiotherapy and multidrug chemotherapy in locally advanced rectal cancer: a dose-escalation study. Am J Clin Oncol 2012; 35: 424-31.
38. Wanebo HJ, Antoniuk P, Koness RJ et al. Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum 1999; 42: 1438-48.
39. Rades D, Kuhn H, Schultze J et al. Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin. Int J Radiat Oncol Biol Phys 2008; 70: 1087-93.
40. Schurr P, Lentz E, Block S et al. Radical redo surgery for local rectal cancer recurrence improves overall survival: a single center experience. J Gastrointest Surg 2008; 12: 1232-8.